Re: Ambulatory Infusions of Lidocaine and Ketamine for Management of Chronic Pain: A Prospective Observational StudyPrimary Investigator:
Dr. Ramin Safakish, MD, FRCPC
Dr. Ramin Safakish, MD, FRCPC
|
We are pleased to announce that the Allevio Pain Management Team is conducting a Prospective Observational Study for the assessment of an intervention to help patients with chronic neuropathic pain. Study participants will be receiving 5 intravenous infusions of lidocaine + ketamine within 2-month intervals between infusions. The intervention will be done at Allevio Pain Management, located at #101 - 240 Duncan Mills Road, Toronto, Ontario. All the infusions will be done under the direct supervision of Anaesthesiologist and Anesthesia Assistant.
|
|
The purpose of the study is to evaluate the effectiveness of lidocaine and ketamine, administered Intravenously. The treatment is covered by OHIP (for residents of Ontario); however, this is an independent study and we do not have a sponsor. Therefore, we cannot pay anything to the patients to cover the cost of their time. If you are interested, click here and make sure your doctor sees the next few pages.